Cargando…

Osteopontin is a prognostic circulating biomarker in patients with neuroendocrine neoplasms

PURPOSE: Osteopontin (OPN), also called secreted phosphoprotein 1 (SPP1) is a matricellular glycoprotein whose expression is elevated in various types of cancer and which has been shown to be involved in tumorigenesis and metastasis in many malignancies. Its role in neuroendocrine neoplasms (NEN) re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kidess, Evelyn, Giesecke, Yvonne, Eichhorn, Ines, Mohr, Raphael, Jann, Henning, Fischer, Christian, Wiedenmann, Bertram, Roderburg, Christoph, Tacke, Frank, Sigal, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423109/ https://www.ncbi.nlm.nih.gov/pubmed/37318593 http://dx.doi.org/10.1007/s00432-023-04979-6

Ejemplares similares

Elevated Flt3L Predicts Long-Term Survival in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms
por: Detjen, Katharina M., et al.
Publicado: (2021)

Primary Neuroendocrine Neoplasms of the Breast: Case Series and Literature Review
por: Özdirik, Burcin, et al.
Publicado: (2020)

PD-L1 – inhibitors in neuroendocrine neoplasia: Results from a real-life study
por: Özdirik, Burcin, et al.
Publicado: (2021)

Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future
por: Stueven, Anna Kathrin, et al.
Publicado: (2019)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies
por: Özdirik, Burcin, et al.
Publicado: (2020)

Analysis of miR-29 Serum Levels in Patients with Neuroendocrine Tumors—Results from an Exploratory Study
por: Özdirik, Burcin, et al.
Publicado: (2020)

The Role of miRNA in the Pathophysiology of Neuroendocrine Tumors
por: Geisler, Lukas, et al.
Publicado: (2021)

Analyses of sex-based clinicopathological differences among patients with gastrointestinal neuroendocrine neoplasms in Europe
por: Jann, Henning, et al.
Publicado: (2023)

A case report of an excellent response to interferon- α in a patient with functional metastasized neuroendocrine tumor refractory to other treatments
por: Özdirik, Burcin, et al.
Publicado: (2020)

Circulating Osteopontin Levels and Outcomes in Patients Hospitalized for COVID-19
por: Hayek, Salim S., et al.
Publicado: (2021)

Serum levels of miR-223 but not miR-21 are decreased in patients with neuroendocrine tumors
por: Hellberg, Teresa, et al.
Publicado: (2020)

Inflammatory Cytokines Associated with Diagnosis, Tumor Grade and Prognosis in Patients with Neuroendocrine Tumors
por: Geisler, Lukas, et al.
Publicado: (2022)

Circulating Levels of Osteopontin Predict Patients’ Outcome after Resection of Colorectal Liver Metastases
por: Loosen, Sven H., et al.
Publicado: (2018)

The Role of Alternative Lymph Node Classification Systems in Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NEN): Superiority of a LODDS Scheme Over N Category in Pancreatic NEN (pNEN)
por: Krieg, Sarah, et al.
Publicado: (2023)

Leptomeningeal Carcinomatosis: A Clinical Dilemma in Neuroendocrine Neoplasms
por: Apostolidis, Leonidas, et al.
Publicado: (2021)

Distribution of gastrointestinal neuroendocrine tumors in Europe: results from a retrospective cross-sectional study
por: Loosen, Sven H., et al.
Publicado: (2022)

A rare case of a patient with a high grade neuroendocrine tumor developing neutropenic sepsis after receiving PRRT combined with Capecitabine or Temozolomide: A case report
por: Özdirik, Burcin, et al.
Publicado: (2021)

Pulmonary Complications in Patients with Liver Cirrhosis
por: Benz, Fabian, et al.
Publicado: (2020)

Preoperative Immunotherapy in Hepatocellular Carcinoma: Current State of the Art
por: Laschtowitz, Alena, et al.
Publicado: (2023)

Systemic treatment in patients with Child–Pugh B liver dysfunction and advanced hepatocellular carcinoma
por: Costa, Frederico, et al.
Publicado: (2023)

Nuclear survivin is a prognosticator in gastroenteropancreatic neuroendocrine neoplasms: a meta-analysis
por: Krieg, Sarah, et al.
Publicado: (2022)

Clinical characteristics of 662 patients with pancreatic neuroendocrine tumors receiving antitumoral therapy
por: Loosen, Sven H., et al.
Publicado: (2022)

Persistently elevated osteopontin serum levels predict mortality in critically ill patients
por: Roderburg, Christoph, et al.
Publicado: (2015)

Transcriptomic Deconvolution of Neuroendocrine Neoplasms Predicts Clinically Relevant Characteristics
por: Otto, Raik, et al.
Publicado: (2023)

In Situ Vaccination as a Strategy to Modulate the Immune Microenvironment of Hepatocellular Carcinoma
por: Lurje, Isabella, et al.
Publicado: (2021)

The Role of Adipokines as Circulating Biomarkers in Critical Illness and Sepsis
por: Loosen, Sven H., et al.
Publicado: (2019)

Circulating tumor cells versus tumor-derived cell-free DNA: rivals or partners in cancer care in the era of single-cell analysis?
por: Kidess, Evelyn, et al.
Publicado: (2013)

An Overview of Circulating Biomarkers in Neuroendocrine Neoplasms: A Clinical Guide
por: Bevere, Michele, et al.
Publicado: (2023)

Challenges in High-grade Neuroendocrine Neoplasms and Mixed Neuroendocrine/Non-neuroendocrine Neoplasms
por: La Rosa, Stefano
Publicado: (2021)

Multicenter Analysis of Treatment Outcomes for Systemic Therapy in Well Differentiated Grade 3 Neuroendocrine Tumors (NET G3)
por: Apostolidis, Leonidas, et al.
Publicado: (2021)

In Vivo Models for Cholangiocarcinoma—What Can We Learn for Human Disease?
por: Mohr, Raphael, et al.
Publicado: (2020)

Angiogenin and osteopontin and coronary collateral circulation
por: Beuy, Joob, et al.
Publicado: (2019)

Circulating Angiogenic Markers in Gastroenteropancreatic Neuroendocrine Neoplasms: A Systematic Review
por: Sandra, Irina, et al.
Publicado: (2022)

Serum levels of circulating microRNA-107 are elevated in patients with early-stage HCC
por: Loosen, Sven H., et al.
Publicado: (2021)

The Diagnostic Approach towards Combined Hepatocellular-Cholangiocarcinoma—State of the Art and Future Perspectives
por: Eschrich, Johannes, et al.
Publicado: (2023)

Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms
por: Corsello, Andrea, et al.
Publicado: (2018)

Whole-genome sequencing of single circulating tumor cells from neuroendocrine neoplasms
por: Childs, Alexa, et al.
Publicado: (2021)

AGTR1 Is Overexpressed in Neuroendocrine Neoplasms, Regulates Secretion and May Potentially Serve as a Target for Molecular Imaging and Therapy
por: Exner, Samantha, et al.
Publicado: (2020)

Circulating MicroRNA-223 Serum Levels Do Not Predict Sepsis or Survival in Patients with Critical Illness
por: Benz, Fabian, et al.
Publicado: (2015)

Atezolizumab and bevacizumab-induced encephalitis in advanced hepatocellular carcinoma: Case report and literature review
por: Özdirik, Burcin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kv816rbmnqb832u5u28mrbuk2l